Dr. Zhao Jingping
赵靖平
Hospital
Second Xiangya Hospital, Central South University, Changsha
Experience
35+ years in psychiatry with focus on schizophrenia research and treatment
Languages
English, Mandarin
Chief Physician; Professor; Doctoral Supervisor; Former Director of Department of Psychiatry; State Council Special Allowance Expert; National Mental Health Expert
China's leading clinical trialist in schizophrenia pharmacotherapy; served as principal investigator for numerous international multi-center clinical trials evaluating novel antipsychotic medications; published over 300 papers in The Lancet, JAMA Psychiatry, American Journal of Psychiatry, and Molecular Psychiatry; played a central role in developing multiple editions of the Chinese Guidelines for the Prevention and Treatment of Schizophrenia; recipient of the State Council Special Allowance for outstanding contributions to psychiatry; contributed to WHO Expert Committees on psychotropic medications; his research has directly influenced antipsychotic prescribing practices nationwide
Dr. Zhao is the top choice for patients with schizophrenia seeking the most current evidence-based pharmacological treatment, particularly those who have not responded adequately to standard antipsychotics. The Second Xiangya Hospital's psychiatry department has one of the highest clinical trial participation rates in China, offering potential access to cutting-edge medications. Patients should bring comprehensive psychiatric treatment records and be prepared to discuss their full medication history in detail.
Research this doctor's background on trusted platforms.
Results are automated searches and may include other individuals with similar names.
Information is provided for reference only and may not reflect current conditions. Please verify directly with the hospital before making decisions.